SHORT MINI FUTURE - PFIZER INC | Market Closed - Swiss Exchange 16:20:00 31/05/2024 BST | ||
| 2.77 CHF | -2.12% |
|
| 1 month | -10.65% | ||
| 3 months | -3.15% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 2.77 | -2.12% |
| 30/05/24 | 2.83 | -1.05% |
| 29/05/24 | 2.86 | +1.78% |
| 28/05/24 | 2.81 | +1.44% |
| 23/05/24 | 2.77 | +1.84% |
Delayed Quote Swiss Exchange
Last update May 31, 2024 at 04:20 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | Bank Julius Bär |
| LPFDJB | |
| ISIN | CH1219348260 |
| Date issued | 05/12/2022 |
| Strike | 58.85 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | - CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 3.12 CHF |
|---|---|
| Lowest since issue | 0.528 CHF |
| Spread | 0.01 CHF |
| Spread % | 0.36% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66
USD
Average target price
31.92
USD
Spread / Average Target
+11.36%
- Stock Market
- Certificates
- LPFDJB Certificat
